Astec IPO Latest News Today

Astec LifeSciences Ltd IPO Listing Detail

Listing Date: Wednesday, November 25, 2009
BSE Script Code: 533138
NSE Symbol: ASTEC
Listing In: B Group of Securities
ISIN: INE563J01010
Issue Price: Rs. 82.00 Per Equity Share
Face Value: Rs. 10.00 Per Equity Share

Astec LifeSciences Ltd IPO will list on Wednesday, November 25, 2009. Issue price of this IPO has been fixed at Rs 82/- per share. Astec LifeSciences IPO subscribed 1.56 times(2.3579 times in retail).

Astec LifeSciences Ltd IPO Listing Detail

Listing Date: Wednesday, November 25, 2009
BSE Script Code: 533138
NSE Symbol: ASTEC
Listing In: B Group of Securities
ISIN: INE563J01010
Issue Price: Rs. 82.00 Per Equity Share
Face Value: Rs. 10.00 Per Equity Share

Astec LifeSciences Ltd IPO allotment Status is now available online.

Astec LifeSciences Ltd IPO was open on Oct 29, 2009 and closed on Nov 04, 2009. IPO was oversubscribed by 1.56 times (2.3579 times in retail).

Astec LifeSciences Ltd IPO allotment Status is now available online.

Astec LifeSciences Ltd IPO was open on Oct 29, 2009 and closed on Nov 04, 2009. IPO was oversubscribed by 1.56 times (2.3579 times in retail).

Astec LifeSciences Ltd IPO fully subscribed on it's closing day. Astec LifeSciences received bids for 1,17,33,525 shares against issue size of 75,00,000 shares. The issue of Astec was open on October 29, 2009, and closes today for subscription on November 04, 2009.

Detailed subscription of Astec LifeSciences IPO on day 4 (Wednesday, November 04, 2009)

Qualified Institutional Buyers (QIBs): 0.6072 Times
Non Institutional Investors: 2.9997 Times
Retail Individual Investors (RIIs): 2.3579 Times
Employees: 0.5010 Times
Total: 1.56 Times

Incorporated in 1994, Astec LifeSciences Limited is engaged in business of Agrochemicals and Pharmaceuticals. Company is primarily involved in the production of active ingredients and intermediates for agrochemicals and pharmaceutical segment. Astec has manufacturing activities at two locations in Maharashtra. one unit at Dombivli, Maharashtra and two units at Mahad, Maharashtra (Unit 1 and Unit 2).

The price band for the issue has been fixed at Rs 77/- at lower level and Rs 82/- at upper level for equity share of Rs 10/-. Astec LifeSciences Ltd is entering in the capital markets with an initial public offering, IPO of 7,500,000 Equity Shares for cash, at a premium to be decided through a 100% Book Built Issue.

The issue will open on October 29, 2009, and closes for subscription on November 04, 2009. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).

Astec LifeSciences Ltd IPO subscribed 0.43 times on it's day 3. Astec LifeSciences received bids for 32,32,500 shares against issue size of 75,00,000 shares. The issue of Astec was open on October 29, 2009, and closes for subscription on November 04, 2009.

Detailed subscription of Astec LifeSciences IPO on day 3 (Tuesday, November 03, 2009)

Qualified Institutional Buyers (QIBs): 0.5220 Times
Non Institutional Investors: 0.0000 Times
Retail Individual Investors (RIIs): 0.4956 Times
Employees: 0.1763 Times
Total: 0.43 Times

Astec LifeSciences Ltd IPO subscribed 0.41 times on it's day 2. Astec LifeSciences received bids for 30,92,700 shares against issue size of 75,00,000 shares. The issue of Astec was open on October 29, 2009, and closes for subscription on November 04, 2009.

Detailed subscription of Astec LifeSciences IPO on day 2 (Friday, October 30, 2009)

Qualified Institutional Buyers (QIBs): 0.5220 Times
Non Institutional Investors: 0.0000 Times
Retail Individual Investors (RIIs): 0.4473 Times
Employees: 0.0270 Times
Total: 0.41 Times

Astec LifeSciences Ltd IPO subscribed 0.27 times on it's day 1. Astec LifeSciences received bids for 20,59,875 shares against issue size of 75,00,000 shares. The issue of Astec is opens today on October 29, 2009, and closes for subscription on November 04, 2009.

Detailed subscription of Astec LifeSciences IPO on day 1 (Thursday, October 29, 2009)

Qualified Institutional Buyers (QIBs): 0.2798 Times
Non Institutional Investors: 0.0000 Times
Retail Individual Investors (RIIs): 0.3957 Times
Employees: 0.0000 Times
Total: 0.27 Times

Incorporated in 1994, Astec LifeSciences Limited is engaged in business of Agrochemicals and Pharmaceuticals. Company is primarily involved in the production of active ingredients and intermediates for agrochemicals and pharmaceutical segment. Astec has manufacturing activities at two locations in Maharashtra. one unit at Dombivli, Maharashtra and two units at Mahad, Maharashtra (Unit 1 and Unit 2).

The price band for the issue has been fixed at Rs 77/- at lower level and Rs 82/- at upper level for equity share of Rs 10/-. Astec LifeSciences Ltd is entering in the capital markets with an initial public offering, IPO of 7,500,000 Equity Shares for cash, at a premium to be decided through a 100% Book Built Issue.

The issue will open on October 29, 2009, and closes for subscription on November 04, 2009. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).

Incorporated in 1994, Astec LifeSciences Limited is engaged in business of Agrochemicals and Pharmaceuticals. Company is primarily involved in the production of active ingredients and intermediates for agrochemicals and pharmaceutical segment. Astec has manufacturing activities at two locations in Maharashtra. one unit at Dombivli, Maharashtra and two units at Mahad, Maharashtra (Unit 1 and Unit 2).

The price band for the issue has been fixed at Rs 77/- at lower level and Rs 82/- at upper level for equity share of Rs 10/-. Astec LifeSciences Ltd is entering in the capital markets with an initial public offering, IPO of 7,500,000 Equity Shares for cash, at a premium to be decided through a 100% Book Built Issue.

The issue will open on October 29, 2009, and closes for subscription on November 04, 2009. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).